Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0001567619-20-020095

Chief Financial Officer sold 1,995 shares at $17.49 ($34,896)

  • Chief Financial Officer acquired 1,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Viret Jean-Frederic · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-11-17 Sale : show line 1 in the form −1,995 $17.49 $34,896 38,769 D
2020-11-17 Exercise or conversion : show line 2 in the form +1,500 $13.50 $20,250 40,269 D
Open-market sales · 1,995 sh · avg $17.49 · $34,896

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-11-17 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −1,500 110,241 D
Loading xslF345X03/doc1.xml…